Navigating the Immune Challenge in Glioblastoma: Exploring Immunotherapeutic Avenues for Overcoming Immune Suppression

Glioblastoma multiforme (GBM) is a primary brain tumor known for its short survival time, typically 14-18 months from diagnosis to fatality. Managing GBM poses significant challenges due to factors like the formidable blood-brain barrier, the immunosuppressive conditions within GBM, and the intricac...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Prateek, Vashist, Shambhavi, Panjiyar, Binay K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611557/
https://www.ncbi.nlm.nih.gov/pubmed/37900496
http://dx.doi.org/10.7759/cureus.46089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611557/
https://www.ncbi.nlm.nih.gov/pubmed/37900496
http://dx.doi.org/10.7759/cureus.46089

Ejemplares similares